Want to see JP:4519 full AI Analyst Report?
Total Valuation
Chugai Pharmaceutical Co has a market cap or net worth of ¥12.16T. The enterprise value is ¥12.03T.
Market Cap¥12.16T
Enterprise Value¥12.03T
Share Statistics
Chugai Pharmaceutical Co has 1,679,057,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,679,057,600
Owned by Insiders―
Owned by Institutions0.08%
Financial Efficiency
Chugai Pharmaceutical Co’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 20.83%.
Return on Equity (ROE)0.21
Return on Assets (ROA)0.18
Return on Invested Capital (ROIC)20.83%
Return on Capital Employed (ROCE)0.29
Revenue Per Employee159.80M
Profits Per Employee55.13M
Employee Count7,872
Asset Turnover0.51
Inventory Turnover1.31
Valuation Ratios
The current PE Ratio of Chugai Pharmaceutical Co is 26.4. Chugai Pharmaceutical Co’s PEG ratio is 2.60.
PE Ratio26.4
PS Ratio10.78
PB Ratio6.70
Price to Fair Value6.70
Price to FCF43.31
Price to Operating Cash Flow26.78
PEG Ratio2.60
Income Statement
In the last 12 months, Chugai Pharmaceutical Co had revenue of 1.26T and earned 434.01B in profits. Earnings per share was 263.73.
Revenue1.26T
Gross Profit894.25B
Operating Income590.19B
Pretax Income597.81B
Net Income434.01B
EBITDA631.37B
Earnings Per Share (EPS)263.73
Cash Flow
In the last 12 months, operating cash flow was 445.51B and capital expenditures -66.87B, giving a free cash flow of 378.64B billion.
Operating Cash Flow445.51B
Free Cash Flow378.64B
Free Cash Flow per Share225.51
Dividends & Yields
Chugai Pharmaceutical Co pays an annual dividend of ¥66, resulting in a dividend yield of 1.17%
Dividend Per Share¥66
Dividend Yield1.17%
Payout Ratio22.90%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.71
52-Week Price Change7.85%
50-Day Moving Average7.61K
200-Day Moving Average8.00K
Relative Strength Index (RSI)41.53
Average Volume (3m)2.77M
Important Dates
Chugai Pharmaceutical Co upcoming earnings date is Jul 24, 2026, Before Open (Confirmed).
Last Earnings DateApr 24, 2026
Next Earnings DateJul 24, 2026
Ex-Dividend Date―
Financial Position
Chugai Pharmaceutical Co as a current ratio of 4.23, with Debt / Equity ratio of 0.92%
Current Ratio4.23
Quick Ratio3.56
Debt to Market Cap0.00
Net Debt to EBITDA-0.68
Interest Coverage Ratio575.24
Taxes
In the past 12 months, Chugai Pharmaceutical Co has paid 163.79B in taxes.
Income Tax163.79B
Effective Tax Rate0.27
Enterprise Valuation
Chugai Pharmaceutical Co EV to EBITDA ratio is 20.81, with an EV/FCF ratio of 41.95.
EV to Sales10.44
EV to EBITDA20.81
EV to Free Cash Flow41.95
EV to Operating Cash Flow33.74
Balance Sheet
Chugai Pharmaceutical Co has ¥850.10B in cash and marketable securities with ¥17.51B in debt, giving a net cash position of ¥832.59B billion.
Cash & Marketable Securities¥850.10B
Total Debt¥17.51B
Net Cash¥832.59B
Net Cash Per Share¥495.87
Tangible Book Value Per Share¥1.20K
Margins
Gross margin is 71.45%, with operating margin of 46.92%, and net profit margin of 34.50%.
Gross Margin71.45%
Operating Margin46.92%
Pretax Margin47.52%
Net Profit Margin34.50%
EBITDA Margin50.19%
EBIT Margin47.60%
Analyst Forecast
The average price target for Chugai Pharmaceutical Co is ¥9,750.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target¥9,750.00
Price Target Upside16.78% Upside
Analyst ConsensusModerate Buy
Analyst Count10
Revenue Growth Forecast5.65%
EPS Growth Forecast10.24%